APO Research
Talk to an analyst

APO RESEARCH · REPORT

γ-Aminobutyric Acid Receptor Agonists

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global γ-Aminobutyric Acid Receptor Agonists Industry Growth and Trends Forecast to 2032

20 December 2025128 pages

Choose your research edition.

Industry Researchγ-Aminobutyric Acid Receptor Agonists Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal γ-Aminobutyric Acid Receptor Agonists Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal γ-Aminobutyric Acid Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal γ-Aminobutyric Acid Receptor Agonists Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal γ-Aminobutyric Acid Receptor Agonists Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global γ-Aminobutyric Acid Receptor Agonists market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for γ-Aminobutyric Acid Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for γ-Aminobutyric Acid Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for γ-Aminobutyric Acid Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of γ-Aminobutyric Acid Receptor Agonists include Akorn, Apotex, CHEPLAPHARM, Hikma, Jazz Pharmaceuicals, Neurelis, SAGE Therapeutics, Sandoz and Torrent Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global γ-Aminobutyric Acid Receptor Agonists market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The γ-Aminobutyric Acid Receptor Agonists market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global γ-Aminobutyric Acid Receptor Agonists market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to γ-Aminobutyric Acid Receptor Agonists.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global γ-Aminobutyric Acid Receptor Agonists market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

γ-Aminobutyric Acid Receptor Agonists Market by Company

Akorn

Apotex

CHEPLAPHARM

Hikma

Jazz Pharmaceuicals

Neurelis

SAGE Therapeutics

Sandoz

Torrent Pharma

Viatris

WG Critical Care

AstraZeneca

Changzhou Siyao Pharmaceutical

Fresenius Kabi

GSK

Sichuan HaiscoPharmaceuical

Huazhong Pharmaceutical

Pfizer

Roche

Mylan

Novartis

Sanofi

Shanghai Pharmaceuticals Holding

Sun Pharma

Teva

Takeda

γ-Aminobutyric Acid Receptor Agonists Segment by Type

GABAA Receptors

GABAB Receptors

GABAC Receptors

γ-Aminobutyric Acid Receptor Agonists Segment by Application

Epilepsy

Anxiety

Neuropathic Pain

Insomnia

Other

γ-Aminobutyric Acid Receptor Agonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global γ-Aminobutyric Acid Receptor Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of γ-Aminobutyric Acid Receptor Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of γ-Aminobutyric Acid Receptor Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of γ-Aminobutyric Acid Receptor Agonists manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of γ-Aminobutyric Acid Receptor Agonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of GABAA Receptors Table 2. Major Company of GABAB Receptors Table 3. Major Company of GABAC Receptors Table 4. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 6. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Type (2021-2026) Table 7. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 8. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Type (2021-2026) Table 9. Global γ-Aminobutyric Acid Receptor Agonists Price by Type (2021-2026) & (US$/Unit) Table 10. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 11. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Type (2027-2032) Table 12. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2027-2032) & (US$ Million) Table 13. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Type (2027-2032) Table 14. Global γ-Aminobutyric Acid Receptor Agonists Price by Type (2027-2032) & (US$/Unit) Table 15. North America γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 16. North America γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 17. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 18. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 22. Latin America γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 25. γ-Aminobutyric Acid Receptor Agonists Industry Trends Table 26. γ-Aminobutyric Acid Receptor Agonists Industry Drivers Table 27. γ-Aminobutyric Acid Receptor Agonists Industry Opportunities and Challenges Table 28. γ-Aminobutyric Acid Receptor Agonists Industry Restraints Table 29. Global γ-Aminobutyric Acid Receptor Agonists Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Company (2021-2026) Table 31. Global γ-Aminobutyric Acid Receptor Agonists Sales by Company (2021-2026) & (K Units) Table 32. Global γ-Aminobutyric Acid Receptor Agonists Sales Share by Company (2021-2026) Table 33. Global γ-Aminobutyric Acid Receptor Agonists Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global γ-Aminobutyric Acid Receptor Agonists Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global γ-Aminobutyric Acid Receptor Agonists Major Company Production Sites and Headquarters Table 36. Global γ-Aminobutyric Acid Receptor Agonists Company, Product Type & Application Table 37. Global γ-Aminobutyric Acid Receptor Agonists Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global γ-Aminobutyric Acid Receptor Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global γ-Aminobutyric Acid Receptor Agonists Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2021-2026) & (K Units) Table 42. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Region (2021-2026) Table 43. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2021-2026) & (US$ Million) Table 44. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Region (2021-2026) Table 45. Global γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2027-2032) & (K Units) Table 47. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Region (2027-2032) Table 48. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2027-2032) & (US$ Million) Table 49. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Region (2027-2032) Table 50. Global γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 53. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Application (2021-2026) Table 54. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 55. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Application (2021-2026) Table 56. Global γ-Aminobutyric Acid Receptor Agonists Price by Application (2021-2026) & (US$/Unit) Table 57. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 58. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Application (2027-2032) Table 59. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2027-2032) & (US$ Million) Table 60. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Application (2027-2032) Table 61. Global γ-Aminobutyric Acid Receptor Agonists Price by Application (2027-2032) & (US$/Unit) Table 62. North America γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 63. North America γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 64. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 65. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 69. Latin America γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 72. Akorn Company Information Table 73. Akorn Business Overview Table 74. Akorn γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Akorn γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 76. Akorn Recent Development Table 77. Apotex Company Information Table 78. Apotex Business Overview Table 79. Apotex γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Apotex γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 81. Apotex Recent Development Table 82. CHEPLAPHARM Company Information Table 83. CHEPLAPHARM Business Overview Table 84. CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 86. CHEPLAPHARM Recent Development Table 87. Hikma Company Information Table 88. Hikma Business Overview Table 89. Hikma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hikma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 91. Hikma Recent Development Table 92. Jazz Pharmaceuicals Company Information Table 93. Jazz Pharmaceuicals Business Overview Table 94. Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 96. Jazz Pharmaceuicals Recent Development Table 97. Neurelis Company Information Table 98. Neurelis Business Overview Table 99. Neurelis γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Neurelis γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 101. Neurelis Recent Development Table 102. SAGE Therapeutics Company Information Table 103. SAGE Therapeutics Business Overview Table 104. SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 106. SAGE Therapeutics Recent Development Table 107. Sandoz Company Information Table 108. Sandoz Business Overview Table 109. Sandoz γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sandoz γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 111. Sandoz Recent Development Table 112. Torrent Pharma Company Information Table 113. Torrent Pharma Business Overview Table 114. Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 116. Torrent Pharma Recent Development Table 117. Viatris Company Information Table 118. Viatris Business Overview Table 119. Viatris γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Viatris γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 121. Viatris Recent Development Table 122. WG Critical Care Company Information Table 123. WG Critical Care Business Overview Table 124. WG Critical Care γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. WG Critical Care γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 126. WG Critical Care Recent Development Table 127. AstraZeneca Company Information Table 128. AstraZeneca Business Overview Table 129. AstraZeneca γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. AstraZeneca γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 131. AstraZeneca Recent Development Table 132. Changzhou Siyao Pharmaceutical Company Information Table 133. Changzhou Siyao Pharmaceutical Business Overview Table 134. Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 136. Changzhou Siyao Pharmaceutical Recent Development Table 137. Fresenius Kabi Company Information Table 138. Fresenius Kabi Business Overview Table 139. Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 141. Fresenius Kabi Recent Development Table 142. GSK Company Information Table 143. GSK Business Overview Table 144. GSK γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. GSK γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 146. GSK Recent Development Table 147. Sichuan HaiscoPharmaceuical Company Information Table 148. Sichuan HaiscoPharmaceuical Business Overview Table 149. Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 151. Sichuan HaiscoPharmaceuical Recent Development Table 152. Huazhong Pharmaceutical Company Information Table 153. Huazhong Pharmaceutical Business Overview Table 154. Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 156. Huazhong Pharmaceutical Recent Development Table 157. Pfizer Company Information Table 158. Pfizer Business Overview Table 159. Pfizer γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Pfizer γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 161. Pfizer Recent Development Table 162. Roche Company Information Table 163. Roche Business Overview Table 164. Roche γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Roche γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 166. Roche Recent Development Table 167. Mylan Company Information Table 168. Mylan Business Overview Table 169. Mylan γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Mylan γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 171. Mylan Recent Development Table 172. Novartis Company Information Table 173. Novartis Business Overview Table 174. Novartis γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Novartis γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 176. Novartis Recent Development Table 177. Sanofi Company Information Table 178. Sanofi Business Overview Table 179. Sanofi γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Sanofi γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 181. Sanofi Recent Development Table 182. Shanghai Pharmaceuticals Holding Company Information Table 183. Shanghai Pharmaceuticals Holding Business Overview Table 184. Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 186. Shanghai Pharmaceuticals Holding Recent Development Table 187. Sun Pharma Company Information Table 188. Sun Pharma Business Overview Table 189. Sun Pharma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. Sun Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 191. Sun Pharma Recent Development Table 192. Teva Company Information Table 193. Teva Business Overview Table 194. Teva γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 195. Teva γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 196. Teva Recent Development Table 197. Takeda Company Information Table 198. Takeda Business Overview Table 199. Takeda γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 200. Takeda γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 201. Takeda Recent Development Table 202. North America γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 203. North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 204. North America γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2026) Table 205. North America γ-Aminobutyric Acid Receptor Agonists Sales Forecast by Country (2027-2032) & (K Units) Table 206. North America γ-Aminobutyric Acid Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 207. North America γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. North America γ-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 209. North America γ-Aminobutyric Acid Receptor Agonists Market Share by Country (2021-2026) Table 210. North America γ-Aminobutyric Acid Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. North America γ-Aminobutyric Acid Receptor Agonists Market Share Forecast by Country (2027-2032) Table 212. Europe γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 213. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 214. Europe γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2026) Table 215. Europe γ-Aminobutyric Acid Receptor Agonists Sales Forecast by Country (2027-2032) & (K Units) Table 216. Europe γ-Aminobutyric Acid Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 217. Europe γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 218. Europe γ-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 219. Europe γ-Aminobutyric Acid Receptor Agonists Market Share by Country (2021-2026) Table 220. Europe γ-Aminobutyric Acid Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 221. Europe γ-Aminobutyric Acid Receptor Agonists Market Share Forecast by Country (2027-2032) Table 222. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 223. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 224. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2026) Table 225. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Forecast by Country (2027-2032) & (K Units) Table 226. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 227. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 228. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 229. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Share by Country (2021-2026) Table 230. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 231. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Share Forecast by Country (2027-2032) Table 232. Latin America γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 233. Latin America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 234. Latin America γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2026) Table 235. Latin America γ-Aminobutyric Acid Receptor Agonists Sales Forecast by Country (2027-2032) & (K Units) Table 236. Latin America γ-Aminobutyric Acid Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 237. Latin America γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 238. Latin America γ-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 239. Latin America γ-Aminobutyric Acid Receptor Agonists Market Share by Country (2021-2026) Table 240. Latin America γ-Aminobutyric Acid Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 241. Latin America γ-Aminobutyric Acid Receptor Agonists Market Share Forecast by Country (2027-2032) Table 242. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 243. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 244. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2026) Table 245. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Forecast by Country (2027-2032) & (K Units) Table 246. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 247. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 248. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 249. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Share by Country (2021-2026) Table 250. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 251. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Share Forecast by Country (2027-2032) Table 252. Key Raw Materials Table 253. Raw Materials Key Suppliers Table 254. γ-Aminobutyric Acid Receptor Agonists Distributors List Table 255. γ-Aminobutyric Acid Receptor Agonists Customers List Table 256. Research Programs/Design for This Report Table 257. Authors List of This Report Table 258. Secondary Sources Table 259. Primary Sources List of Figures Figure 1. γ-Aminobutyric Acid Receptor Agonists Image Figure 2. Global γ-Aminobutyric Acid Receptor Agonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global γ-Aminobutyric Acid Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 4. Global γ-Aminobutyric Acid Receptor Agonists Sales (2021-2032) & (K Units) Figure 5. GABAA Receptors Image Figure 6. Global GABAA Receptors Sales YoY Growth (2021-2032) & (K Units) Figure 7. GABAB Receptors Image Figure 8. Global GABAB Receptors Sales YoY Growth (2021-2032) & (K Units) Figure 9. GABAC Receptors Image Figure 10. Global GABAC Receptors Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global γ-Aminobutyric Acid Receptor Agonists Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global γ-Aminobutyric Acid Receptor Agonists Market Share by Type 2025 VS 2032 Figure 13. North America γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 14. North America γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 15. Europe γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 16. Europe γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 19. Latin America γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 20. Latin America γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 γ-Aminobutyric Acid Receptor Agonists Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Epilepsy Image Figure 26. Global Epilepsy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Anxiety Image Figure 28. Global Anxiety Sales YoY Growth (2021-2032) & (K Units) Figure 29. Neuropathic Pain Image Figure 30. Global Neuropathic Pain Sales YoY Growth (2021-2032) & (K Units) Figure 31. Insomnia Image Figure 32. Global Insomnia Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global γ-Aminobutyric Acid Receptor Agonists Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global γ-Aminobutyric Acid Receptor Agonists Market Share by Application 2025 VS 2032 Figure 37. North America γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 38. North America γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 39. Europe γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 40. Europe γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 43. Latin America γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 44. Latin America γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 47. North America γ-Aminobutyric Acid Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America γ-Aminobutyric Acid Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America γ-Aminobutyric Acid Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe γ-Aminobutyric Acid Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe γ-Aminobutyric Acid Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America γ-Aminobutyric Acid Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America γ-Aminobutyric Acid Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America γ-Aminobutyric Acid Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. γ-Aminobutyric Acid Receptor Agonists Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. γ-Aminobutyric Acid Receptor Agonists Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • GABAA Receptors
  • GABAB Receptors
  • GABAC Receptors
Applications
  • Epilepsy
  • Anxiety
  • Neuropathic Pain
  • Insomnia
  • Other
Companies covered
  • Akorn
  • Apotex
  • CHEPLAPHARM
  • Hikma
  • Jazz Pharmaceuicals
  • Neurelis
  • SAGE Therapeutics
  • Sandoz
  • Torrent Pharma
  • Viatris
  • WG Critical Care
  • AstraZeneca
  • Changzhou Siyao Pharmaceutical
  • Fresenius Kabi
  • GSK
  • Sichuan HaiscoPharmaceuical
  • Huazhong Pharmaceutical
  • Pfizer
  • Roche
  • Mylan
  • Novartis
  • Sanofi
  • Shanghai Pharmaceuticals Holding
  • Sun Pharma
  • Teva
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global γ-Aminobutyric Acid Receptor Agonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global γ-Aminobutyric Acid Receptor Agonists Sales Estimates and Forecasts (2021-2032)
  5. 1.3 γ-Aminobutyric Acid Receptor Agonists Market by Type
  6. 1.3.1 GABAA Receptors
  7. 1.3.2 GABAB Receptors
  8. 1.3.3 GABAC Receptors
  9. 1.4 Global γ-Aminobutyric Acid Receptor Agonists Market Size by Type
  10. 1.4.1 Global γ-Aminobutyric Acid Receptor Agonists Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global γ-Aminobutyric Acid Receptor Agonists Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global γ-Aminobutyric Acid Receptor Agonists Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America γ-Aminobutyric Acid Receptor Agonists Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe γ-Aminobutyric Acid Receptor Agonists Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America γ-Aminobutyric Acid Receptor Agonists Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 γ-Aminobutyric Acid Receptor Agonists Industry Trends
  2. 2.2 γ-Aminobutyric Acid Receptor Agonists Industry Drivers
  3. 2.3 γ-Aminobutyric Acid Receptor Agonists Industry Opportunities and Challenges
  4. 2.4 γ-Aminobutyric Acid Receptor Agonists Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2026)
  2. 3.2 Global Top Players by γ-Aminobutyric Acid Receptor Agonists Sales (2021-2026)
  3. 3.3 Global Top Players by γ-Aminobutyric Acid Receptor Agonists Price (2021-2026)
  4. 3.4 Global γ-Aminobutyric Acid Receptor Agonists Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global γ-Aminobutyric Acid Receptor Agonists Major Company Production Sites & Headquarters
  6. 3.6 Global γ-Aminobutyric Acid Receptor Agonists Company, Product Type & Application
  7. 3.7 Global γ-Aminobutyric Acid Receptor Agonists Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global γ-Aminobutyric Acid Receptor Agonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 γ-Aminobutyric Acid Receptor Agonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 γ-Aminobutyric Acid Receptor Agonists Tier 1, Tier 2, and Tier 3
4 γ-Aminobutyric Acid Receptor Agonists Regional Status and Outlook
  1. 4.1 Global γ-Aminobutyric Acid Receptor Agonists Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global γ-Aminobutyric Acid Receptor Agonists Historic Market Size by Region
  3. 4.2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global γ-Aminobutyric Acid Receptor Agonists Sales in Value by Region (2021-2026)
  5. 4.2.3 Global γ-Aminobutyric Acid Receptor Agonists Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global γ-Aminobutyric Acid Receptor Agonists Forecasted Market Size by Region
  7. 4.3.1 Global γ-Aminobutyric Acid Receptor Agonists Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global γ-Aminobutyric Acid Receptor Agonists Sales in Value by Region (2027-2032)
  9. 4.3.3 Global γ-Aminobutyric Acid Receptor Agonists Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 γ-Aminobutyric Acid Receptor Agonists by Application
  1. 5.1 γ-Aminobutyric Acid Receptor Agonists Market by Application
  2. 5.1.1 Epilepsy
  3. 5.1.2 Anxiety
  4. 5.1.3 Neuropathic Pain
  5. 5.1.4 Insomnia
  6. 5.1.5 Other
  7. 5.2 Global γ-Aminobutyric Acid Receptor Agonists Market Size by Application
  8. 5.2.1 Global γ-Aminobutyric Acid Receptor Agonists Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global γ-Aminobutyric Acid Receptor Agonists Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global γ-Aminobutyric Acid Receptor Agonists Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America γ-Aminobutyric Acid Receptor Agonists Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe γ-Aminobutyric Acid Receptor Agonists Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America γ-Aminobutyric Acid Receptor Agonists Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Akorn
  2. 6.1.1 Akorn Company Information
  3. 6.1.2 Akorn Business Overview
  4. 6.1.3 Akorn γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Akorn γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  6. 6.1.5 Akorn Recent Developments
  7. 6.2 Apotex
  8. 6.2.1 Apotex Company Information
  9. 6.2.2 Apotex Business Overview
  10. 6.2.3 Apotex γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Apotex γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  12. 6.2.5 Apotex Recent Developments
  13. 6.3 CHEPLAPHARM
  14. 6.3.1 CHEPLAPHARM Company Information
  15. 6.3.2 CHEPLAPHARM Business Overview
  16. 6.3.3 CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  18. 6.3.5 CHEPLAPHARM Recent Developments
  19. 6.4 Hikma
  20. 6.4.1 Hikma Company Information
  21. 6.4.2 Hikma Business Overview
  22. 6.4.3 Hikma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hikma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  24. 6.4.5 Hikma Recent Developments
  25. 6.5 Jazz Pharmaceuicals
  26. 6.5.1 Jazz Pharmaceuicals Company Information
  27. 6.5.2 Jazz Pharmaceuicals Business Overview
  28. 6.5.3 Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  30. 6.5.5 Jazz Pharmaceuicals Recent Developments
  31. 6.6 Neurelis
  32. 6.6.1 Neurelis Company Information
  33. 6.6.2 Neurelis Business Overview
  34. 6.6.3 Neurelis γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Neurelis γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  36. 6.6.5 Neurelis Recent Developments
  37. 6.7 SAGE Therapeutics
  38. 6.7.1 SAGE Therapeutics Company Information
  39. 6.7.2 SAGE Therapeutics Business Overview
  40. 6.7.3 SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  42. 6.7.5 SAGE Therapeutics Recent Developments
  43. 6.8 Sandoz
  44. 6.8.1 Sandoz Company Information
  45. 6.8.2 Sandoz Business Overview
  46. 6.8.3 Sandoz γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sandoz γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  48. 6.8.5 Sandoz Recent Developments
  49. 6.9 Torrent Pharma
  50. 6.9.1 Torrent Pharma Company Information
  51. 6.9.2 Torrent Pharma Business Overview
  52. 6.9.3 Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  54. 6.9.5 Torrent Pharma Recent Developments
  55. 6.10 Viatris
  56. 6.10.1 Viatris Company Information
  57. 6.10.2 Viatris Business Overview
  58. 6.10.3 Viatris γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Viatris γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  60. 6.10.5 Viatris Recent Developments
  61. 6.11 WG Critical Care
  62. 6.11.1 WG Critical Care Company Information
  63. 6.11.2 WG Critical Care Business Overview
  64. 6.11.3 WG Critical Care γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 WG Critical Care γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  66. 6.11.5 WG Critical Care Recent Developments
  67. 6.12 AstraZeneca
  68. 6.12.1 AstraZeneca Company Information
  69. 6.12.2 AstraZeneca Business Overview
  70. 6.12.3 AstraZeneca γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 AstraZeneca γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  72. 6.12.5 AstraZeneca Recent Developments
  73. 6.13 Changzhou Siyao Pharmaceutical
  74. 6.13.1 Changzhou Siyao Pharmaceutical Company Information
  75. 6.13.2 Changzhou Siyao Pharmaceutical Business Overview
  76. 6.13.3 Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  78. 6.13.5 Changzhou Siyao Pharmaceutical Recent Developments
  79. 6.14 Fresenius Kabi
  80. 6.14.1 Fresenius Kabi Company Information
  81. 6.14.2 Fresenius Kabi Business Overview
  82. 6.14.3 Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  84. 6.14.5 Fresenius Kabi Recent Developments
  85. 6.15 GSK
  86. 6.15.1 GSK Company Information
  87. 6.15.2 GSK Business Overview
  88. 6.15.3 GSK γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 GSK γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  90. 6.15.5 GSK Recent Developments
  91. 6.16 Sichuan HaiscoPharmaceuical
  92. 6.16.1 Sichuan HaiscoPharmaceuical Company Information
  93. 6.16.2 Sichuan HaiscoPharmaceuical Business Overview
  94. 6.16.3 Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  96. 6.16.5 Sichuan HaiscoPharmaceuical Recent Developments
  97. 6.17 Huazhong Pharmaceutical
  98. 6.17.1 Huazhong Pharmaceutical Company Information
  99. 6.17.2 Huazhong Pharmaceutical Business Overview
  100. 6.17.3 Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  102. 6.17.5 Huazhong Pharmaceutical Recent Developments
  103. 6.18 Pfizer
  104. 6.18.1 Pfizer Company Information
  105. 6.18.2 Pfizer Business Overview
  106. 6.18.3 Pfizer γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Pfizer γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  108. 6.18.5 Pfizer Recent Developments
  109. 6.19 Roche
  110. 6.19.1 Roche Company Information
  111. 6.19.2 Roche Business Overview
  112. 6.19.3 Roche γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Roche γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  114. 6.19.5 Roche Recent Developments
  115. 6.20 Mylan
  116. 6.20.1 Mylan Company Information
  117. 6.20.2 Mylan Business Overview
  118. 6.20.3 Mylan γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Mylan γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  120. 6.20.5 Mylan Recent Developments
  121. 6.21 Novartis
  122. 6.21.1 Novartis Company Information
  123. 6.21.2 Novartis Business Overview
  124. 6.21.3 Novartis γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Novartis γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  126. 6.21.5 Novartis Recent Developments
  127. 6.22 Sanofi
  128. 6.22.1 Sanofi Company Information
  129. 6.22.2 Sanofi Business Overview
  130. 6.22.3 Sanofi γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Sanofi γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  132. 6.22.5 Sanofi Recent Developments
  133. 6.23 Shanghai Pharmaceuticals Holding
  134. 6.23.1 Shanghai Pharmaceuticals Holding Company Information
  135. 6.23.2 Shanghai Pharmaceuticals Holding Business Overview
  136. 6.23.3 Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  138. 6.23.5 Shanghai Pharmaceuticals Holding Recent Developments
  139. 6.24 Sun Pharma
  140. 6.24.1 Sun Pharma Company Information
  141. 6.24.2 Sun Pharma Business Overview
  142. 6.24.3 Sun Pharma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Sun Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  144. 6.24.5 Sun Pharma Recent Developments
  145. 6.25 Teva
  146. 6.25.1 Teva Company Information
  147. 6.25.2 Teva Business Overview
  148. 6.25.3 Teva γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Teva γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  150. 6.25.5 Teva Recent Developments
  151. 6.26 Takeda
  152. 6.26.1 Takeda Company Information
  153. 6.26.2 Takeda Business Overview
  154. 6.26.3 Takeda γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Takeda γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  156. 6.26.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America γ-Aminobutyric Acid Receptor Agonists Sales by Country
  2. 7.1.1 North America γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026)
  4. 7.1.3 North America γ-Aminobutyric Acid Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 7.2 North America γ-Aminobutyric Acid Receptor Agonists Market Size by Country
  6. 7.2.1 North America γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America γ-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026)
  8. 7.2.3 North America γ-Aminobutyric Acid Receptor Agonists Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country
  2. 8.1.1 Europe γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026)
  4. 8.1.3 Europe γ-Aminobutyric Acid Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 8.2 Europe γ-Aminobutyric Acid Receptor Agonists Market Size by Country
  6. 8.2.1 Europe γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe γ-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026)
  8. 8.2.3 Europe γ-Aminobutyric Acid Receptor Agonists Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Country
  2. 9.1.1 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Size by Country
  6. 9.2.1 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America γ-Aminobutyric Acid Receptor Agonists Sales by Country
  2. 10.1.1 South America γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026)
  4. 10.1.3 South America γ-Aminobutyric Acid Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 10.2 South America γ-Aminobutyric Acid Receptor Agonists Market Size by Country
  6. 10.2.1 South America γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America γ-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026)
  8. 10.2.3 South America γ-Aminobutyric Acid Receptor Agonists Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country
  2. 11.1.1 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size by Country
  6. 11.2.1 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 γ-Aminobutyric Acid Receptor Agonists Value Chain Analysis
  2. 12.1.1 γ-Aminobutyric Acid Receptor Agonists Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 γ-Aminobutyric Acid Receptor Agonists Production Mode & Process
  7. 12.2 γ-Aminobutyric Acid Receptor Agonists Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 γ-Aminobutyric Acid Receptor Agonists Distributors
  10. 12.2.3 γ-Aminobutyric Acid Receptor Agonists Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst